Csutak A, Steiber Z, Tozser J, Jakab A, Berta A, Silver D
PLoS One. 2017; 12(5):e0177003.
PMID: 28472076
PMC: 5417609.
DOI: 10.1371/journal.pone.0177003.
Whawell S, Vipond M, Scott-Coombes D, Thompson J
Br J Surg. 1993; 80(1):107-9.
PMID: 8428265
PMC: 11437531.
DOI: 10.1002/bjs.1800800134.
Yamamoto M, Sawaya R, Mohanam S, Rao V, Bruner J, Nicolson G
J Neurooncol. 1994; 22(2):139-51.
PMID: 7745466
DOI: 10.1007/BF01052889.
Laiho M, Saksela O, Andreasen P, Keski-Oja J
J Cell Biol. 1986; 103(6 Pt 1):2403-10.
PMID: 3491081
PMC: 2114602.
DOI: 10.1083/jcb.103.6.2403.
Keski-Oja J, Blasi F, Leof E, Moses H
J Cell Biol. 1988; 106(2):451-9.
PMID: 3276718
PMC: 2114980.
DOI: 10.1083/jcb.106.2.451.
Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor.
Antalis T, Clark M, Barnes T, Lehrbach P, Devine P, Schevzov G
Proc Natl Acad Sci U S A. 1988; 85(4):985-9.
PMID: 3257578
PMC: 279685.
DOI: 10.1073/pnas.85.4.985.
Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.
Masson C, Angles-Cano E
Biochem J. 1988; 256(1):237-44.
PMID: 3146972
PMC: 1135393.
DOI: 10.1042/bj2560237.
Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf R, van den Berg E, Schleuning W
J Cell Biol. 1988; 106(3):971-8.
PMID: 3126194
PMC: 2115076.
DOI: 10.1083/jcb.106.3.971.
Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.
Andreasen P, Pyke C, Riccio A, Kristensen P, Nielsen L, Lund L
Mol Cell Biol. 1987; 7(8):3021-5.
PMID: 3118190
PMC: 367928.
DOI: 10.1128/mcb.7.8.3021-3025.1987.
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.
Knudsen B, HARPEL P, Nachman R
J Clin Invest. 1987; 80(4):1082-9.
PMID: 3116043
PMC: 442350.
DOI: 10.1172/JCI113164.
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.
Lund L, Riccio A, Andreasen P, Nielsen L, Kristensen P, Laiho M
EMBO J. 1987; 6(5):1281-6.
PMID: 3111844
PMC: 553930.
DOI: 10.1002/j.1460-2075.1987.tb02365.x.
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.
Pollanen J, Saksela O, Salonen E, Andreasen P, Nielsen L, Dano K
J Cell Biol. 1987; 104(4):1085-96.
PMID: 3104349
PMC: 2114427.
DOI: 10.1083/jcb.104.4.1085.
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
Genton C, Kruithof E, Schleuning W
J Cell Biol. 1987; 104(3):705-12.
PMID: 3102504
PMC: 2114546.
DOI: 10.1083/jcb.104.3.705.
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.
Ginsburg D, Zeheb R, Yang A, Rafferty U, Andreasen P, Nielsen L
J Clin Invest. 1986; 78(6):1673-80.
PMID: 3097076
PMC: 423941.
DOI: 10.1172/JCI112761.
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.
Ny T, Sawdey M, Lawrence D, Millan J, Loskutoff D
Proc Natl Acad Sci U S A. 1986; 83(18):6776-80.
PMID: 3092219
PMC: 386592.
DOI: 10.1073/pnas.83.18.6776.
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.
Blasi F, Vassalli J, Dano K
J Cell Biol. 1987; 104(4):801-4.
PMID: 3031083
PMC: 2114431.
DOI: 10.1083/jcb.104.4.801.
Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils.
Remold-ODonnell E, Nixon J, Rose R
J Exp Med. 1989; 169(3):1071-86.
PMID: 2926322
PMC: 2189272.
DOI: 10.1084/jem.169.3.1071.
Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator.
de Serrano V, Urano T, Gaffney P, Castellino F
J Protein Chem. 1989; 8(1):61-77.
PMID: 2527513
DOI: 10.1007/BF01025079.
Clinical disorders of fibrinolysis: a critical review.
Francis Jr R
Blut. 1989; 59(1):1-14.
PMID: 2526671
DOI: 10.1007/BF00320240.
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
Wohlwend A, Belin D, Vassalli J
J Exp Med. 1987; 165(2):320-39.
PMID: 2434595
PMC: 2188521.
DOI: 10.1084/jem.165.2.320.
